Drug Sustained- release of Artificial Bone with PLGA Coating Triple Anti- TB Drugs in Vitro

yan junfa,wang qian,shi jiandang,liu haitao,wang zili,geng guangqi,wang jie
DOI: https://doi.org/10.16050/j.cnki.issn1674-6309.2015.06.013
2015-01-01
Abstract:Objective To observe the control release of c alcium sulphate / polyaminoacids bone with polylactic acid / polyglycolic acid copolymer( PLGA) coating triple anti- tuberculosis drugs in vitro. Methods According to optimized formulation,the drug- loaded and non- drug- loaded artificial bones were prepared in the dark environment. Then they were coated with PLGA solution. After drying and sterilizing,they had been soaked in simulated body fluid for the release test. Drug- released concentrations in different periods were measured by HPLC. Three drugs were isoniazid( INH),rifampicin( RFP),pyrazinamide( PZA). Results The released drugs from triple anti- TB drugs artificial bone complex with PLGA coating,after 3 days,the concerntration of INH was( 62. 32 ± 1. 20) μg · m L- 1,RFP was( 2. 84 ± 0. 32) μg · m L- 1,PZA was( 214. 28 ± 9. 53) μg·m L- 1. After 19 weeks,the concentration of INH was( 0. 52 ± 0. 12) μg·m L- 1. After18 weeks,RFP was( 1. 46 ± 0. 33( μg·m L- 1. After 20 weeks,PZA was( 0. 69 ± 0. 03) μg·m L- 1. The released drugs from triple anti- TB drugs artificial bone complex with PLGA coating as follows: isoniazid was43. 51% of total drug- loaded at 17 weeks while at 16 weeks,rifampin was 15. 92% and pyrazinamide was48. 42%. Drug peak did not appear in blank control group during the effect time. Conclusion Artificial bone with PLGA coating rriple anti- tuberculous drugs could release drug stably and slowly and maintain a relative high drug concentration.
What problem does this paper attempt to address?